Literature DB >> 7819462

Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F2 alpha in the ovine corpus luteum in vivo.

W J McGuire1, J L Juengel, G D Niswender.   

Abstract

Experiment I was designed to determine the optimal dose of phorbol 12-myristate 13-acetate (PMA) that inhibited progesterone production when infused into the ovarian artery. The most efficacious dose of PMA was 2 mumol. Experiment II was designed to determine whether activation of protein kinase C (PKC) inhibited progesterone production without initiating luteolysis. Ewes received ovarian arterial infusions of 4 alpha-phorbol (2 mumol, n = 4), PMA (2 mumol, n = 8), or prostaglandin F2 alpha (PGF2 alpha; 1 mumol, n = 5). Concentrations of progesterone in serum decreased by 3 h in PMA-treated ewes and by 5 h in PGF2 alpha treated ewes (p < 0.05). By 48 h, serum levels of progesterone in PMA-treated ewes had returned to control values; but in PGF2 alpha-treated ewes they remained low for the duration of the experiment. Luteal weights and progesterone contents at 48 h were similar in 4 alpha-phorbol- and PMA-treated ewes but were decreased in PGF2 alpha-treated ewes (p < 0.05). Experiment III was designed to determine whether PGF2 alpha or PKC activation induced oligonucleosome formation or influenced mRNA levels for cytochrome P450sec or 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD). Ewes received treatments as in experiment II, and CL were collected at 3, 12, or 24 h (n = 3-4 per group). Luteal weights were decreased (p < 0.05) and oligonucleosome formation was increased (p < 0.05) in PGF2 alpha-treated ewes compared to controls or to PMA-treated ewes by 12 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819462     DOI: 10.1095/biolreprod51.4.800

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  Ovine prostaglandin F2alpha receptor: steroid influence on steady-state levels of luteal mRNA.

Authors:  P B Hoyer; S L Marion; I Stine; B R Rueda; D L Hamernik; J W Regan; M E Wise
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

2.  Comparison of mRNA levels for the PGF(2α) receptor (FP) during luteolysis and early pregnancy in the ovine corpus luteum.

Authors:  B R Rueda; I W Botros; K L Pierce; J W Regan; P B Hoyer
Journal:  Endocrine       Date:  1995-11       Impact factor: 3.633

3.  Steady-state concentrations of mRNA encoding the receptor for luteinizing hormone during the estrous cycle and following prostaglandin F(2α) treatment of ewes.

Authors:  M K Guy; J L Juengel; T R Tandeski; G D Niswender
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

4.  Concentration of mRNA encoding 3 beta-hydroxysteroid dehydrogenase/delta 5,delta 4 isomerase (3 beta-HSD) and 3 beta-HSD enzyme activity following treatment of ewes with prostaglandin F2 alpha.

Authors:  J L Juengel; B M Meberg; E W McIntush; M F Smith; G D Niswender
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

5.  Luteal expression of steroidogenic factor-1 mRNA during the estrous cycle and in response to luteotropic and luteolytic stimuli in ewes.

Authors:  J L Juengel; T L Larrick; B M Meberg; G D Niswender
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.